A bleomycin/ifosfamide/cisplatin regimen exhibits poor activity against persistent or recurrent squamous gynecologic cancers

K. Behbakht, L. S. Massad, E. L. Yordan, S. H. Lincoln, J. A.H. Eriksson, L. Winkelman, K. DeGeest, C. Kirschner, G. D. Wilbanks

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint Dive into the research topics of 'A bleomycin/ifosfamide/cisplatin regimen exhibits poor activity against persistent or recurrent squamous gynecologic cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences